| Current Price | $6.40 | Mkt Cap | $276.6M |
|---|---|---|---|
| Open | $6.28 | P/E Ratio | 0.00 |
| Prev. Close | $6.40 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.16 - $6.47 | Volume | 231,622 |
| 52-Wk Range | $3.53 - $10.02 | Avg. Daily Vol. | 453,588 |
| Current Price | $6.40 | Mkt Cap | $276.6M |
|---|---|---|---|
| Open | $6.28 | P/E Ratio | 0.00 |
| Prev. Close | $6.40 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.16 - $6.47 | Volume | 231,622 |
| 52-Wk Range | $3.53 - $10.02 | Avg. Daily Vol. | 453,588 |
The best Bull and Bear pitches based on recency and number of recommendations.
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock… More
Read the most recent pitches from players about EIGR.
Recs
oscillation
(75.04)
Submitted: 5/28/2015 9:24:56 AM :
Start Price:
$32.40
NASDAQ:EIGR Score:
-159.93
nev
Recs
treasureoaks
(< 20)
Submitted: 4/22/2015 3:54:19 PM :
Start Price:
$203.85
NASDAQ:EIGR Score:
-177.91
Oversold.
Recs
Jimbyrnes1969
(< 20)
Submitted: 4/9/2015 1:25:22 PM :
Start Price:
$252.36
NASDAQ:EIGR Score:
-180.57
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.
Find the members with the highest scoring picks in EIGR.
GreenAB (29.90) Score: +180.05
The Score Leader is the player with the highest score across all their picks in EIGR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| GreenAB | 29.90 | 3/20/2015 |
|
NS | $405.00 | -98.43% | +81.62% | +180.05 | 0 Comment | |
| IdahoInvestor | 28.07 | 8/17/2015 |
|
5Y | $15.75 | -59.56% | +82.70% | +142.26 | 0 Comment | |
| PAGEBOY2020 | 61.37 | 8/13/2021 |
|
5Y | $8.85 | -27.98% | -14.42% | -13.56 | 0 Comment | |
| XMFFlygal | 98.75 | 6/10/2022 |
|
3M | $5.66 | +12.54% | -3.43% | -15.98 | 0 Comment | |
| jonboy13 | 91.31 | 11/24/2021 |
|
5Y | $6.44 | -1.09% | -18.57% | -17.48 | 0 Comment | |
|
OneBee | 20.36 | 5/4/2021 |
|
3M | $8.67 | -26.53% | -8.36% | -18.17 | 0 Comment |
| sikiliza | < 20 | 3/13/2020 |
|
5Y | $5.71 | +11.56% | +44.87% | -33.31 | 0 Comment | |
| foggs1 | 65.38 | 3/17/2021 |
|
5Y | $10.12 | -37.06% | -3.35% | -33.71 | 0 Comment | |
| odocoileus | 44.04 | 9/10/2020 |
|
5Y | $10.48 | -39.22% | +13.85% | -53.06 | 0 Comment | |
| drugtrader | 56.25 | 7/8/2020 |
|
5Y | $9.43 | -32.45% | +21.88% | -54.33 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
